Clinical Trial Update: Safety and Efficacy Study Using Rexin-G for Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and efficacy study of Rexin-G in breast cancer reported preliminary safety and anti-tumor activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Rexin-G

Snippet

Sponsor: Epeius Biotechnologies | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED